By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Company name Ulta Salon, Cosmetics & Fragrance, Inc.
Stock ticker ULTA
Live stock price [stckqut]ULTA[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $106.43
Target stock price (averages with growth) $149.56
Target stock price (averages with no growth) $114.8
Target stock price (manual assumptions) $106.22

The following company description is from Google Finance: http://www.google.com/finance?q=ulta

Ulta Salon, Cosmetics & Fragrance, Inc. (Ulta) is a beauty retailer, which provides one-stop shopping for prestige, mass and salon products and salon services in the United States. During the year ended January 28, 2012 (fiscal 2011), the Company opened 61 new stores. It operates full-service salons in all of its stores. Its Ulta store format includes an open and modern salon area with approximately eight to 10 stations. The entire salon area is approximately 950 square feet with a concierge desk, skin treatment room, semi-private shampoo and hair color processing areas. Each salon is a full-service salon offering hair cuts, hair coloring and permanent texture, with salons also providing facials and waxing.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Ulta Salon, Cosmetics & Fragrance, Inc. as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns. I am going to leave Ulta on my Watch List in the hopes that it improves some of its fundamentals.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Ulta Salon, Cosmetics & Fragrance, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(s2member_level1)]
In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

Stock price at the time of the calculation: $85.43

Growth: 0.15

Current EPS (TTM): $3.15

P/E: 27

Future EPS Calc: $6.33

Future Stock Price Calc: $171.06

Target stock price: $106.21

I hope that this makes you a better investor. [/s2If]

By:
On:
In: Poor company, Stock analysis
Tagged:
With: 0 Comments

Company name Symmetry Medical Inc.
Stock ticker SMA
Live stock price [stckqut]SMA[/stckqut]
Confident Investor Rating Poor

The following company description is from Google Finance: http://www.google.com/finance?q=sma

Symmetry Medical Inc. (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry. The Company operates in two segments: original equipment manufacturer (OEM) solutions and symmetry surgical. On August 15, 2011, the Company acquired PSC Industries, Inc’s Olsen Medical division. On December 29, 2011 it acquired the surgical instruments product portfolio from Codman & Shurtleff, Inc., a Johnson & Johnson Company.
Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in Symmetry Medical Inc. It is not possible to confidently invest in a company that is not currently profitable.
If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name GlaxoSmithKline plc (ADR)
Stock ticker GSK
Live stock price [stckqut]GSK[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Fair
Sales growth Poor
EPS growth Good
P/E growth Good
EBIT growth Fair

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $53.11
Target stock price (averages with growth) $56.37
Target stock price (averages with no growth) $45.17
Target stock price (manual assumptions) $52.6

The following company description is from Google Finance: http://www.google.com/finance?q=gsk

GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK’s principal pharmaceutical products include medicines in therapeutic areas: respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines and human immunodeficiency virus (HIV). The Company operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. On January 30, 2013, GSK acquired additional 29.3% interest in GlaxoSmithKline Consumer Healthcare Ltd. In May 2013, GlaxoSmithKline PLC acquired Okairos AG. In December 2013, Suntory Beverage & Food Ltd fully acquired Lucozade Ribena Suntory Limited from GlaxoSmithKline plc.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in GlaxoSmithKline plc (ADR) as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(s2member_level1)]
In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

Stock price at the time of the calculation: $53.03

Growth: 0.1

Current EPS (TTM): $2.63

P/E: 20

Future EPS Calc: $4.23

Future Stock Price Calc: $84.71

Target stock price: $52.6

I hope that this makes you a better investor. [/s2If]

By:
On:
In: Commentary
With: 0 Comments

When asked if they would rather be smart or dumb, surely everyone would answer smart! If you’re looking to improve your mental capabilities you can start by following in the footsteps of some of the smartest people in the world.

A person’s Intelligence Quotient indicates their mental abilities relative to others of approximately the same age.

  • Average IQ= 100
  • Above Average=115
  • Genius= 140
  • Extraordinary Genius=160

I have often wrote that you do not need to be a genius to invest in the market. In fact, the market is not always kind to smart people. Most of the math is adequately done with math that you learned in 4th grade math class. Even still, it is interesting to look at the habits (good and bad) of those that appear to be extremely intelligent.

 

The Habits of Smart People
Source: Online-PhD-Programs.org

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Company name Ulta Salon, Cosmetics & Fragrance, Inc.
Stock ticker ULTA
Live stock price [stckqut]ULTA[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Fair
Sales growth Good
EPS growth Good
P/E growth Fair
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $150.42
Target stock price (averages with growth) $205.87
Target stock price (averages with no growth) $140.8
Target stock price (manual assumptions) $140.05

The following company description is from Google Finance: http://www.google.com/finance?q=ulta

Ulta Salon, Cosmetics & Fragrance, Inc. (Ulta) is a beauty retailer, which provides one-stop shopping for prestige, mass and salon products and salon services in the United States. During the year ended January 28, 2012 (fiscal 2011), the Company opened 61 new stores. It operates full-service salons in all of its stores. Its Ulta store format includes an open and modern salon area with approximately eight to 10 stations. The entire salon area is approximately 950 square feet with a concierge desk, skin treatment room, semi-private shampoo and hair color processing areas. Each salon is a full-service salon offering hair cuts, hair coloring and permanent texture, with salons also providing facials and waxing.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.